Altre lingue Qiagen N.V. Xetra

Azioni

QIA

NL0015001WM6

Mercato chiuso - Xetra Altri mercati azionari 17:35:11 24/04/2024			Variaz. 5gg	Var. 1 gen.
38,58 ^EUR	-0,89%		+4,48%	-5,03%

22/04	I titoli azionari europei chiudono in rialzo nelle contrattazioni di lunedì; la Commissione Europea indaga su TikTok per possibili violazioni delle DSA	MT
16/04	QIAGEN NV : Deutsche Bank conferma il rating Buy	ZD

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance	24/04
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	22/04
WOCHENVORSCHAU/29. April bis 5. Mai (18. KW)	19/04
Bosch setzt auf Wachstum mit Medizintechnik - neuer Sepsis-Test	10/04
QIAGEN N.V. to release results for Q1 2024 and hold webcast	09/04
Qiagen N : launches new solution for screening of sexual assault forensic casework samples	04/04
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024	03/04
Qiagen N.V. Strengthens Its Portfolio for Cancer Research, Showcases Latest Product Launches At AACR Annual Meeting 2024	03/04
Mybio Are the New Exclusive Partner for Qiagen in Ireland & Northern Ireland	27/03
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system	25/03
QIAGEN Introduces QIAstat-Dx Analyzer 2.0 with Remote Test Results Access, Enhancing Collaboration Across Healthcare System	25/03
MARKT-AUSBLICK/DAX auf dem Weg zur 20.000er Marke	22/03
Qiagen Teams Up With Physicians Association for Tuberculosis Screening Program	18/03
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements	18/03
BLICKPUNKT/DAX-Dividende steigt auf Rekordsumme von 53,15 Mrd EUR	18/03
Qiagen N : Virtual Exane Conference Investor Introduction	12/03
Qiagen N : TD Cowen Healthcare Conference March 5-6 Investor Introduction	12/03
QIAGEN announces Form 20-F annual report filing for 2023 results	11/03
For the UK: QIAGEN Ltd statement about the Modern Slavery Act 2015 for 2024	06/03
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery	27/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

QIAGEN : Q4 in linea; le prospettive di business di routine rimangono intatte

07 febbraio 2024 alle 16:30